Literature DB >> 2420879

Characterization of cell lines expressing mutant I-Ab and I-Ak molecules allows the definition of distinct serologic epitopes on A alpha and A beta polypeptides.

B N Beck, J M Buerstedde, C J Krco, A E Nilson, C G Chase, D J McKean.   

Abstract

A series of seven I-Ab-reactive monoclonal antibodies (mAb) has been derived from a BALB/c anti-C57BL/6 immunization. Analysis of the reactivity patterns of these mAb with spleen cells of mice from the independent haplotypes has revealed three groups of mAb: group I mAb react with all haplotypes except d, group II with all except d and k, and group III with all except d, k, and j. In addition, the group I and group II mAb also react with human class II-expressing cells. We have used these mAb to isolate one mutant I-Ab-expressing cell line and three additional I-Ak mutant cell lines. These antibodies have been used, in conjunction with a large panel of I-A-reactive mAb available from others, to extensively characterize our collection of mutant I-A-expressing cell lines. Analysis of the mutant cell lines has allowed us to assign the reactivity of each mAb to either the A alpha- or the A beta-polypeptide. All seven newly isolated mAb appear to react with determinants on the A alpha-polypeptide. Furthermore, analysis of the panel of A alpha k- and A beta k-mutants has allowed us to discriminate at least five epitopes that are separable by mutation on the A beta k-polypeptide, and two epitopes on the A alpha k-polypeptide.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420879

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  The contribution of beta-strand residues to serologic epitopes on the A beta k polypeptide.

Authors:  B N Beck; A E Nilson; M P Bell; C G Chase; D J McKean
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11.

Authors:  C I Pearson; A M Gautam; I C Rulifson; R S Liblau; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

3.  Haplotype-specific differences in signaling by transfected class II molecules to a Ly-1+ B-cell clone.

Authors:  G A Bishop; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Existence of mixed isotype A beta E alpha class II molecules in Ed alpha gene-introduced C57BL/6 transgenic mice.

Authors:  T Mineta; K Seki; M Matsunaga; M Kimoto
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

5.  Altered I-A protein-mediated transmembrane signaling in B cells that express truncated I-Ak protein.

Authors:  W F Wade; Z Z Chen; R Maki; S McKercher; E Palmer; J C Cambier; J H Freed
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  A single base mutation in an I-A alpha-chain gene alters T-cell recognition.

Authors:  I J Griffith; E M Choi; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

7.  Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.

Authors:  T Crompton; R K Lees; H Pircher; H R MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

8.  Evidence for a single-niche model of positive selection.

Authors:  M Merkenschlager; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

9.  A mutational analysis of the Abetaz/Aalphad major histocompatibility complex class II molecule that restricts autoreactive T cells in (NZBxNZW)F1 mice. The critical influence of alanine at position 69 in the Aalphad chain.

Authors:  T Sai; M Mine; M Fukuoka; S Koarada; M Kimoto
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

10.  Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells.

Authors:  Sue Tsai; Pau Serra; Xavier Clemente-Casares; Jun Yamanouchi; Shari Thiessen; Robyn M Slattery; John F Elliott; Pere Santamaria
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.